Student coaching: How far can technology go? P Oreopoulos, U Petronijevic Journal of Human Resources 53 (2), 299-329, 2018 | 167 | 2018 |
Can genetically based clines in plant defence explain greater herbivory at higher latitudes? DN Anstett, JR Ahern, J Glinos, N Nawar, JP Salminen, MTJ Johnson Ecology letters 18 (12), 1376-1386, 2015 | 66 | 2015 |
PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia JM Gawel, AE Shouksmith, YS Raouf, N Nawar, K Toutah, S Bukhari, ... European Journal of Medicinal Chemistry, 112411, 2020 | 36 | 2020 |
Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting MM Hassan, J Israelian, N Nawar, G Ganda, P Manaswiyoungkul, ... Journal of Medicinal Chemistry, 2020 | 32 | 2020 |
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia K Toutah, N Nawar, S Timonen, H Sorger, YS Raouf, S Bukhari, J von Jan, ... Journal of Medicinal Chemistry, 2021 | 28 | 2021 |
Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia AE Shouksmith, JM Gawel, N Nawar, D Sina, YS Raouf, S Bukhari, L He, ... ACS Medicinal Chemistry Letters 11 (1), 56-64, 2019 | 24 | 2019 |
Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma N Nawar, S Bukhari, AA Adile, Y Suk, P Manaswiyoungkul, K Toutah, ... Journal of Medicinal Chemistry, 2022 | 18 | 2022 |
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype OO Olaoye, PR Watson, N Nawar, M Geletu, A Sedighi, S Bukhari, ... Journal of Medicinal Chemistry 64 (5), 2691-2704, 2021 | 17 | 2021 |
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma HK Garcha, N Nawar, H Sorger, F Erdogan, MMK Aung, A Sedighi, ... Pharmaceuticals 15 (11), 1321, 2022 | | 2022 |
Evaluation of Small-Molecule HDAC Inhibitors Through In Vitro and In Cellulo Approaches N Nawar, HK Garcha, A Sedighi, ED de Araujo, PT Gunning HDAC/HAT Function Assessment and Inhibitor Development: Methods and …, 2022 | | 2022 |
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lym HK Garcha, N Nawar, H Sorger, F Erdogan, MMK Aung, A Sedighi, ... Pharmaceutics 15 (11)), 2022 | | 2022 |
Halogenated phenylsulfonamide hydroxamic acid compounds, compositions and uses thereof as selective hdac6 inhibitors PT Gunning, O Olaoye, K Toutah, AE Shouksmith, JM Shouksmith, ... US Patent App. 17/593,877, 2022 | | 2022 |